Cite
APA Citation
Goldschmidt, N., Horowitz, N. A., Heffes, V., Darawshy, F., Mashiach, T., Shaulov, A., Gatt, M. E., & Dann, E. J. (2019). addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. Leukemia & lymphoma, 60(8), 1890–1898. http://access.bl.uk/ark:/81055/vdc_100087067640.0x00002d